Some men can delay prostate cancer treatment: panel

Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health said on Wednesday.

The panel backed the so-called active monitoring approach to prostate cancer treatment as a way to help men avoid the potential health consequences of treatment, which include impotence and incontinence.

The panel also urged the NIH for more research to clarify the best strategies for managing prostate cancer.

Prostate cancer is the most common non-skin cancer in men in the United States.

(Editing by Jackie Frank)